These findings implicate mitochondrial metabolism in the pathogenesis and progression of at least certain subsets of cancers, including HNSCC; if in part regulated by β2AR, as suggested by the data herein, this may represent a therapeutically targetable pathway. Here, ADRB2 is linked to cancer.